Parallel Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-62
| Closed | -$975 | – | 3443 |
|
|
2024
Q1 | $975 | Hold |
62
| – | – | ﹤0.01% | 2936 |
|
|
2023
Q4 | $1K | Sell |
62
-186
| -75% | -$3K | ﹤0.01% | 2931 |
|
|
2023
Q3 | $3.16K | Hold |
248
| – | – | ﹤0.01% | 2670 |
|
|
2023
Q2 | $3.49K | Hold |
248
| – | – | ﹤0.01% | 2562 |
|
|
2023
Q1 | $3.83K | Hold |
248
| – | – | ﹤0.01% | 2507 |
|
|
2022
Q4 | $4.07K | Sell |
248
-7
| -3% | -$115 | ﹤0.01% | 2426 |
|
|
2022
Q3 | $5K | Buy |
255
+7
| +3% | +$137 | ﹤0.01% | 2320 |
|
|
2022
Q2 | $3K | Buy |
248
+215
| +652% | +$2.6K | ﹤0.01% | 2494 |
|
|
2022
Q1 | $0 | Sell |
33
-641
| -95% | – | ﹤0.01% | 3353 |
|
|
2021
Q4 | $7K | Buy |
674
+587
| +675% | +$6.1K | ﹤0.01% | 2278 |
|
|
2021
Q3 | $3K | Buy |
87
+77
| +770% | +$2.66K | ﹤0.01% | 2594 |
|
|
2021
Q2 | $0 | Sell |
10
-25
| -71% | – | ﹤0.01% | 3086 |
|
|
2021
Q1 | $2K | Buy |
35
+25
| +250% | +$1.43K | ﹤0.01% | 2524 |
|
|
2020
Q4 | $1K | Sell |
10
-30
| -75% | -$3K | ﹤0.01% | 2497 |
|
|
2020
Q3 | $2K | Sell |
40
-28
| -41% | -$1.4K | ﹤0.01% | 2350 |
|
|
2020
Q2 | $4K | Buy |
+68
| New | +$4K | ﹤0.01% | 2041 |
|